Literature DB >> 23482

Renal function in patients with multiple myeloma.

R A DeFronzo, C R Cooke, J R Wright, R L Humphrey.   

Abstract

Renal tubular and glomerular functions were evaluated in 35 consecutive patients with multiple myeloma and were correlated with changes in renal histopathology and myeloma protein patterns. All nine patients without Bence Jones proteinuria had CCr greater than 50 ml/min. In contrast 16/26 patients with Bence Jones proteinuria had CCr less than 50 ml/min and the magnitude of the Bence Jones proteinuria correlated well with the degree of renal insufficiency. Frequent abnormalities in renal tubular acidifying and concentrating ability were observed only in patients with Bence Jones proteinuria and occurred in the absence of significant reductions of glomerular filtration rate. Severely deranged renal histology was seen only in patients with Bence Jones proteinuria and consisted primarily of tubular atrophy and degeneration; glomeruli appeared normal. These data suggest that Bence Jones proteins exert a direct nephrotoxic effect at the tubular level with resultant tubular dysfunction and tubular atrophy. Glomerular filtration rate remains relatively preserved despite the significant abnormalities of tubular function. Although obstructing tubular casts were observed only in patients with severely impaired glomerular filtration rate, many patients with similarly impaired renal function had no evidence of such casts. Instead, tubular atrophy and degeneration correlated best with renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23482     DOI: 10.1097/00005792-197803000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  17 in total

1.  The kidney in myeloma.

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

2.  Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo.

Authors:  P W Sanders; G A Herrera; A Chen; B B Booker; J H Galla
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 3.  Renal lesions in dysproteinemias.

Authors:  P Verroust; L Morel-Maroger; J L Preud'Homme
Journal:  Springer Semin Immunopathol       Date:  1982

Review 4.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

5.  Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage.

Authors:  M C Diemert; L Musset; O Gaillard; S Escolano; A Baumelou; F Rousselet; J Galli
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

7.  Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins.

Authors:  P W Sanders; B B Booker; J B Bishop; H C Cheung
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Renal plasma clearance: a valuable marker in myelomatosis.

Authors:  O P Hansen; A Drivsholm
Journal:  Blut       Date:  1982-07

9.  Alpha-1-microglobulin: an indicator protein for renal tubular function.

Authors:  H Yu; Y Yanagisawa; M A Forbes; E H Cooper; R A Crockson; I C MacLennan
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

10.  Use of a renal tubule cell line (LLC-PK1) to study the nephrotoxic potential of a kappa-type Bence-Jones protein.

Authors:  M C Diemert; V Tricottet; L Benel; G Descamps; E Escolano; J Galli; M Reynès; F Rousselet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.